Last reviewed · How we verify
NCT02961309: MJCIG
A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking
Phase 1 trial testing THC in Tobacco Use in 9 participants. Completed in 30 September 2019.
24 April 2019
Quick facts
| Lead sponsor | Battelle Memorial Institute |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 9 |
| Start date | 7 May 2018 |
| Primary completion | 24 April 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- THC — full drug profile →
Conditions studied
- Tobacco Use — all drugs for Tobacco Use →
Sponsor
Battelle Memorial Institute
Who can join
18 and older, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the proposed research is to investigate how smoking increasing potency of THC (i.e., the psychoactive ingredient in marijuana) changes tobacco cigarette smoking behavior, urges, subjective effects, and abuse liability. This study will be a within-subjects, placebo-controlled study in our clinical laboratory of the effect of active vs. placebo marijuana on cigarette puff topography, exhaled carbon monoxide, urge, subjective effects, and abuse liability among 7 adults who smoke both marijuana and tobacco cigarettes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02961309
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of THC
Trials testing the same drug.
- NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
- NCT06878417 — Cannabinoids for Osteoarthritis Pain Effectiveness Trial · NA · recruiting
- NCT06859710 — THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy · Phase 1 · recruiting
- NCT05641766 — Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural · Phase 2 · not yet recruiting
- NCT07146945 — A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers · Phase 1 · not yet recruiting
Other recruiting trials for Tobacco Use
Currently open trials in the same condition.
- NCT07162935 — Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY) · NA · recruiting
- NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
- NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
- NCT06983678 — Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron · NA · recruiting
- NCT06922617 — STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking · NA · recruiting
Other Battelle Memorial Institute trials
Trials by the same sponsor.
- NCT05128994 — Hand Grasp Function After Spinal Cord Injury · NA · completed
- NCT06207240 — Functional Electrical Stimulation Therapy After Stroke · NA · completed
- NCT04314713 — A Study to Evaluate the Intramuscular Administration of Scopolamine · Phase 1 · terminated
- NCT03994926 — Evaluation of an Eye Tracking Sensor to Detect Cannabis Impairment · EARLY_PHASE1 · terminated
- NCT03546790 — Laboratory Smoking of Marijuana "Blunts" · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02961309 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Battelle Memorial Institute
- Last refreshed: 2 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02961309.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing